Latest California Healthline Stories
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
Both sides in the contentious and expensive battle over California’s Proposition 8 are cherry-picking the facts ahead of Tuesday’s vote as dialysis companies spend record amounts to persuade voters through ads.
Dialysis companies have contributed more than $110 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — breaking the $109 million record set by the pharmaceutical industry in 2016.
Consumers favor ACA’s safeguards on the promise that patients who have health problems can get insurance. In the heat of the midterm campaigns, politicians in both parties agree, but their arguments don’t always add up.
The measure, which will appear on the November ballot, seeks to cap industry profits. The SEIU-UHW union has raised almost $17 million, but opponents from the industry have invested more than four times that.
Children in some California counties visit emergency rooms for asthma at nearly double the statewide rate, which experts attribute largely to air pollution that is likely to worsen as wildfires and other environmental disasters increase in severity.
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll — both human and financial — is enormous, finds an investigation by KHN and the Chicago Tribune.